NTNU Discovery

What NTNU Discovery does

NTNU Discovery is a university-based pre-commercial funding program operated by NTNU (Norwegian University of Science and Technology) in collaboration with Helse Midt-Norge (Central Norway Regional Health Authority) and Sparebank 1 SMN (a regional Norwegian savings bank). Established in 2011 through a regional initiative involving Nord-Trøndelag and Sør-Trøndelag county municipalities, Sparebank 1 SMN, and NTNU, the program distributes grants to employees and students at NTNU and Helse Midt-Norge to develop commercially viable products from early-stage research. The program has two full-time project managers (Jan Hassel, Håvard Wibe) based at Hovedbygget, NTNU Trondheim, and operates from a single headquarters in Trondheim, Norway. Since inception, it has distributed approximately 150 million NOK across 500 projects, with roughly half of funded projects maturing into companies, 92% remaining active after three years, and alumni companies (including Kahoot, Seram Coating, Blueeye Robotics, and Aviant) collectively generating over 2 billion NOK in combined revenue.

The program offers two core funding tiers: a preliminary project (forprosjekt) of up to 75,000 NOK for students and 200,000 NOK for employees, accepting applications year-round, and a main project (hovedprosjekt) of up to 300,000 NOK for students and 1,000,000 NOK for employees, awarded semi-annually. Student preliminary-project applicants must first obtain the Aneo-bidraget via Spark*NTNU as a pre-qualification step. The 2026 main-project portfolio spans virus-based gene therapy (EDGE-Tx), ALS drug development (Revie-001, partnered with Lead Discovery Center in Dortmund), glioblastoma treatment (GBM-SYNERG4), nanoprinted heart rhythm sensors (OptoPatch), rotating transformers for renewable energy (FR-PRO), 3D-printed plastic components (PolyMEX), wireless newborn monitoring (Naere Medical), aquaculture decision tools (DuxPace), construction error prevention (Turnip), and mathematical cloud-cost optimization (SlashCloud.io). Sterling Road provides complementary 10,000 NOK software-project grants for NTNU students and alumni.

NTNU Discovery is not a commercial revenue-generating entity. Its economic model is a grant-distribution mechanism funded by NTNU, Helse Midt-Norge, and Sparebank 1 SMN, with no subscription, equity participation, or fee structure. Its commercial significance is indirect: NTNU Discovery functions as a pre-seed validator whose support acts as a credibility signal for subsequent external investors, and alumni-founded companies have generated 111+ incorporated entities with combined revenue exceeding 2 billion NOK. The program is not separately incorporated — it operates as an internal university initiative under NTNU with joint governance from its three institutional backers.

Name

NTNU Discovery

Legal name

NTNU Discovery

Website

https://ntnudiscovery.no

Company type

Private

Founded year

2011

Operating status

Operating

Short description

NTNU Discovery is a university pre-commercial funding program that distributes grants of up to 1,000,000 NOK to NTNU and Helse Midt-Norge students and employees to commercialize early-stage research into products and companies.

Ownership category

akta.pro rank

Product category

Academic Research Commercialization Funding

akta.pro primary industry

Research & Science Grantmaking Foundations (BPAGAKAI)

akta.pro secondary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Pre-seed grant funding
• University startup grants
• Research commercialization funding
• Academic technology transfer
• Early-stage product funding

Headquarters

HQ city

Bergen

HQ country

Norway

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Pre-commercial grant funding: NTNU Discovery does not generate commercial revenue. It distributes grant funding to early-stage projects from NTNU, Helse Midt-Norge, and Sparebank 1 SMN. Funding is awarded in two categories: preliminary projects (forprosjekt) and main projects (hovedprosjekt). There is no revenue from products or services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

NTNU Discovery is a university-operated pre-commercial grant funding program that distributes non-dilutive capital to students and employees of NTNU (Norwegian University of Science and Technology) and Helse Midt-Norge for early-stage product development and commercialization of research. The program offers two core funding categories — preliminary projects (forprosjekt) up to 75,000-200,000 NOK and main projects (hovedprosjekt) up to 300,000-1,000,000 NOK — to support feasibility testing and concept validation when no external investors are willing to commit.

Product overview

NTNU Discovery is a financial support scheme for developing commercially viable business ideas from employees and students at NTNU and Helse Midt-Norge. The organization offers two core funding programs: Forprosjekt (pre-project funding up to 75,000-200,000 NOK) and Hovedprosjekt (main project funding up to 300,000-1,000,000 NOK). The portfolio includes diverse projects spanning biotechnology (gene therapy, drug development), renewable energy, medical devices, cloud computing optimization, and industrial applications. Notable projects include Revie-001 (ALS drug candidate), SlashCloud.io (cloud cost optimization), OptoPatch (cardiac sensor), and PolyMEX (3D printed metal replacement components).

Differentiator

Problem solved

Functional benefit

Products and services

• Forprosjekt (Pre-project Funding) Seed funding for projects in the very early stages. Students can receive up to 75,000 NOK and employees up to 200,000 NOK for feasibility studies and initial development. Applications are accepted year-round. Students must first obtain the Aneo-bidraget as a pre-qualification step.
• Hovedprosjekt (Main Project Funding) Major project funding for more developed concepts that have progressed beyond preliminary feasibility. Students can receive up to 300,000 NOK and employees up to 1,000,000 NOK. Funding is awarded twice yearly and presented at public events such as StartupTRD.

Quantifiable outcome

• 92% of supported projects remain active after 3 years
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Partnerships

Six partnerships are on record, tiered core and minor.

• NTNU (Norwegian University of Science and Technology)coreStrategic or Co-development Partner · 1 January 2011NTNU is one of the three main financial backers of NTNU Discovery and the host institution for the program. The university provides institutional infrastructure, access to researchers and students, and co-funding for the grant program. NTNU Discovery was established through a regional initiative including NTNU, Sparebank 1 SMN, and regional county municipalities.
• Helse Midt-Norge (Health Central Norway)coreStrategic or Co-development Partner · 1 January 2011Helse Midt-Norge (Health Central Norway Regional Health Authority) co-finances NTNU Discovery and provides access to healthcare researchers and clinical expertise. Employees and students affiliated with Helse Midt-Norge are eligible to apply for funding. Projects in areas such as medical technology, drug development, and health informatics are supported.
• Aneo (via Spark*NTNU)minorGTM or Marketing PartnerStudents must first obtain the Aneo-bidraget (Aneo contribution) via Spark*NTNU before applying to NTNU Discovery for preliminary project funding. Aneo provides up to 25,000 NOK in initial support and a dedicated mentor. This is a pre-qualification pathway for student applicants.
• Sterling RoadminorGTM or Marketing PartnerSterling Road provides 10,000 NOK grants plus coaching to NTNU students and alumni with software projects. While not required as a prerequisite for NTNU Discovery, it serves as an alternative or complementary early-stage funding source listed alongside NTNU Discovery's own financing options.
• Lead Discovery Center (LDC), DortmundcoreStrategic or Co-development PartnerNTNU researchers working on the Revie-001 ALS drug candidate collaborate with LDC, an internationally leading early-phase drug development organization with ~90 scientists. LDC provided access to specialized testing infrastructure and methods, and helped secure approximately 18 million NOK from the KHAN-I fund. LDC helps NTNU researchers progress toward pharma industry licensing.
• StartupTRDminorGTM or Marketing PartnerStartupTRD is a Trondheim-based startup ecosystem organization that hosts the main project award ceremony for NTNU Discovery. The public event provides visibility for funded projects and connects researchers with the local startup community.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• NTNU Technology Transfer Office (NTNU TTO): The technology transfer office of NTNU itself, operating within the same parent university to commercialize research output. NTNU Discovery functions alongside NTNU TTO in the same ecosystem, and TTO referrals are an explicit mid-funnel channel for the program.
• Chalmers Ventures: A Swedish university-linked pre-seed and seed investor that commercializes research from Chalmers University of Technology. Closely comparable model: university-affiliated early-stage funding for academic founders, with operating support and connections to industry.
• Karolinska Institutet Innovations: The innovation arm of Sweden's Karolinska Institutet, focused on commercializing medical and life-sciences research. Closely comparable to NTNU Discovery's health-focused stream supported by Helse Midt-Norge, with similar pre-commercial grant/incubation activity for clinical researchers.
• SPARK Norway: A Norway-based, Stanford SPARK-affiliated program that supports translational life-sciences research projects through mentorship and milestone-driven funding. Operates in the same pre-seed grantmaking niche for academic medical researchers as NTNU Discovery's Helse Midt-Norge stream.
• University of Oslo Innovation (UiO): University of Oslo's innovation support programs, which provide commercialization assistance and funding for Oslo-based academic founders. Comparable Norwegian university pre-seed commercialization function, though at the country's largest university.

Broad incumbents

• Innovation Norway: Norway's national innovation and development agency, offering grants, loans, and advisory services to Norwegian startups. A broader incumbent providing complementary innovation funding across the country, of which NTNU Discovery is one specialized channel.
• Research Council of Norway (Norges Forskningsråd): The Norwegian government's principal funding agency for research, providing larger R&D grants to academic projects. Overlaps with NTNU Discovery in funding academic research but operates at much larger scale and across all disciplines nationally.
• SINTEF: Scandinavia's largest independent research institute, conducting contract R&D for Norwegian industry and commercializing research output. Related broader institutional player in Norwegian applied research commercialization, though not a grantmaking program.

Emerging players

• Y Combinator: The world's largest pre-seed accelerator, providing small amounts of funding and intensive mentorship to early-stage founders globally. Comparable pre-seed function to NTNU Discovery but operates commercially with equity participation, at vastly larger scale and global reach.
• SOSV: A global accelerator and venture capital firm operating vertical-specific programs (IndieBio, HAX, etc.) for early-stage deep-tech and life-sciences startups. Comparable pre-seed function for science-based founders, but commercial model with global scope versus NTNU Discovery's regional non-dilutive approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ntnu-discovery

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NTNU Discovery